|
KR20130027576A
|
|
Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
|
|
CN104188989A
|
|
Composition and method for reducing drug levels in tissues when orotate derivative is given
|
|
US2007179145A1
|
|
Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives
|
|
US2008025949A1
|
|
Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
|
|
US2006189640A1
|
|
Method of increasing drug oral bioavailability and compositions of less toxic orotate salts
|
|
US2005232813A1
|
|
Specimen collecting, processing and analytical assembly
|
|
WO02084557A1
|
|
Computerized evaluation of risk in financing technologies
|
|
US6184227B1
|
|
Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
|
